TickerFacts.

Palvella Therapeutics, Inc. (PVLA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

Older than the company's other figures. The latest EBITDA is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Depreciation & Amortization, which EBITDA is computed from, under the concepts TickerFacts maps.

-$9.96M
Year ended 2023-12-31
2021-12-31: -$49.37M2022-12-31: -$40.70M2023-12-31: -$9.96M-$9.96M
2021-12-31 EBITDA (USD) 2023-12-31
Period endedEBITDAChange YoYSource filing
2023-12-31-$9.96Mn/m2025-03-31, From 2023-01-01
2022-12-31-$40.70Mn/m2024-03-29, From 2022-01-01
2021-12-31-$49.37Mn/a2023-03-31, From 2021-01-01